Upgrades and Downgrades - Page 58 | TalkMarkets

Content

All Posts > Content under Upgrades and Downgrades
913 to 928 of 2365 Posts
<<< 1 ... 56 57 58 59 60 ... 148 >>>
Redfin Upgraded To Overweight From Neutral At Piper Jaffray
Article By: The Fly
Monday, April 1, 2019 9:00 AM EDT
Piper Jaffray analyst Jason Deleeuw upgraded Redfin to Overweight from Neutral and raised his price target for the shares to $26 from $17.
In this article: RDFN
Read
XPO Looks 'Increasingly Attractive' As A Takeover Target, Says Jefferies
Article By: The Fly
Saturday, March 30, 2019 7:30 PM EDT
Jefferies analyst David Kerstens lowered his price target for XPO Logistics to $92 from $120 but he believes XPO looks "increasingly attractive as a takeover target."
In this article: XPO
Read
Morgan Stanley Downgrades Yeti To Equal Weight After Stock Doubled Year-To-Date
Article By: The Fly
Friday, March 29, 2019 10:25 AM EDT
Morgan Stanley analyst Kimberly Greenberger downgraded Yeti to Equal Weight from Overweight, stating that while she remains constructive on the company's long-term outlook.
In this article: YETI
Read
Tesla Price Target Lowered To $215 From $230 At JPMorgan
Article By: The Fly
Friday, March 29, 2019 9:07 AM EDT
JPMorgan analyst Ryan Brinkman lowered his price target for Tesla to $215 from $230 and keeps an Underweight rating on the name after meeting with management.
In this article: TSLA
Read
Piper Analysis Shows Apple Shares May Have Upside 'Well Into' The $200s
Article By: The Fly
Wednesday, March 27, 2019 6:23 AM EDT
Piper Jaffray analyst Michael Olson believes that as upgrade rates for Apple devices have lengthened and the predictability of new iPhone uptake has become challenging, the company is pushing high margin and highly recurring services offerings.
In this article: AAPL
Read
Piper Continues To Recommend Biogen Shares After Deeper Dive On BIIB067
Article By: The Fly
Tuesday, March 26, 2019 6:18 AM EDT
Piper Jaffray analyst Christopher Raymond continues to recommend Biogen shares after a deeper dive on BIIB067, an antisense oligonucleotide targeting SOD1 for the treatment of SOD1-amyotrophic lateral sclerosis. W
In this article: BIIB
Read
William Blair Starts 'Still Scratching The Surface' MongoDB At Outperform
Article By: The Fly
Friday, March 22, 2019 11:49 AM EDT
William Blair analyst Jason Ader initiated coverage of MongoDB with an Outperform saying he expects the company to post "strong" top-line growth for the next several years.
In this article: MDB
Read
JPMorgan Upgrades Lumentum To Overweight On Iphone Volume Stabilization
Article By: The Fly
Friday, March 22, 2019 8:53 AM EDT
JPMorgan analyst Samik Chatterjee upgraded Lumentum Holdings to Overweight from Neutral and raised his price target for the shares to $65 from $50.
In this article: LITE Also: AAPL
Read
Goldman Joins Seven Others In Downgrading Biogen On Alzheimer's Failure
Article By: The Fly
Thursday, March 21, 2019 11:41 AM EDT
Goldman Sachs analyst Terence Flynn downgraded Biogen to Neutral from Buy after the company announced plans to discontinue its global Phase 3 program for Alzheimer's drug candidate aducanumab.
In this article: BIIB
Read
Biogen Price Target Lowered To $280 From $402 At Piper Jaffray
Article By: The Fly
Thursday, March 21, 2019 8:51 AM EDT
Piper Jaffray analyst Christopher Raymond lowered his price target for Biogen shares to $280 from $402 after the company announced the discontinuation of aducanumab development in mild Alzheimer's disease.
In this article: BIIB
Read
Goldman Upgrades Qorvo To Buy On Smartphone Stabilization, 5G Strength
Article By: The Fly
Thursday, March 21, 2019 6:41 AM EDT
Goldman Sachs analyst Toshiya Hari last night upgraded Qorvo to Buy from Neutral and raised his price target for the shares to $79 from $66.
In this article: QRVO Also: AAPL
Read
Monster Beverage Downgraded To Neutral From Conviction Buy At Goldman Sachs
Article By: The Fly
Wednesday, March 20, 2019 6:07 AM EDT
Goldman Sachs analyst Judy Hong downgraded Monster Beverage to Neutral from Buy and removed the shares from her firm's Americas Conviction List.
In this article: MNST
Read
Align Technology Price Target Raised To $300 From $250 At Piper Jaffray
Article By: The Fly
Tuesday, March 19, 2019 6:27 AM EDT
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $300 from $250 and reiterates an Overweight rating on the shares.
In this article: ALGN
Read
Upwork: Substantial Upside Opportunity In Workforce Mobility
Article By: Alpha Insights
Monday, March 18, 2019 8:02 PM EDT
Upwork went public on October 3, 2018, just before the stock market went through a major dive. Following a high on March 1, this pullback offers a solid entry for a company with substantial opportunity and compelling value proposition.
In this article: UPWK
Read
Okta Upgraded To Buy From Neutral At Goldman Sachs
Article By: The Fly
Monday, March 18, 2019 6:45 AM EDT
Goldman Sachs analyst Heather Bellini upgraded Okta to Buy from Neutral and raised her price target for the shares to $94 from $80.
In this article: OKTA
Read
Amazon Wins Another Bull After KeyBanc Upgrades Stock
Article By: Benzinga
Friday, March 15, 2019 11:16 AM EDT
Amazon.com, Inc. AMZN accelerated its profitability over the last few years, and one analyst suspects targeted efforts to improve retail margins will drive an impending inflection. At time of publication, Amazon's stock traded at $1,699 per share.
In this article: AMZN
Read
913 to 928 of 2365 Posts
<<< 1 ... 56 57 58 59 60 ... 148 >>>